How long does Wegovy take to work, and what should you expect?

The real question: are you seeing the right things at each stage?

Many people starting Wegovy focus on the scales, but the more useful early signal is appetite. A gentle reduction in how much food it takes to feel satisfied is the first thing the medicine tends to produce, often within the first couple of weeks at 0.25 mg. Weight changes at this stage are usually modest, and that is expected. The 0.25 mg starting dose is there to let your body adjust to the medicine, not to deliver the full therapeutic effect. Chasing a large number on the scales in week two is the wrong frame.

A practical habit worth building early: before each weekly injection, take one minute to note whether your portions have changed or whether you have naturally stopped before finishing a plate. That brief check gives you a better picture of how the medicine is working than the scales alone. You can read more about the broader mechanism on our guide to how Wegovy works if the science behind this is useful context.

By months two and three, as the dose steps up to 0.5 mg then 1.0 mg, most people begin to see weight change on the scales. Nausea and other gastrointestinal symptoms often intensify briefly after each step-up before settling. That pattern is normal, and it is one reason prescribers move through the schedule gradually rather than starting at the highest dose.

Why the timeline is longer than most people expect

The STEP 1 trial followed participants for 68 weeks at the 2.4 mg maintenance dose, and the average weight reduction across that period was around 15%, as published in the New England Journal of Medicine. Those results did not accumulate in equal instalments each week. Weight loss with GLP-1 medicines typically follows a curve: slower early on, accelerating once the maintenance dose is reached, then plateauing as the body reaches a new equilibrium.

The newer 7.2 mg maintenance dose, approved by the MHRA in January 2026 and subsequently refined with a dedicated single-dose pen approved in April 2026, reported around 20.7% average weight loss over 72 weeks in trials. That higher ceiling is reached through the same step-wise titration, starting at 0.25 mg, which means the journey to it is several months long regardless of the final dose.

It is also worth understanding that the speed of response varies between individuals. Genetics, starting weight, metabolic rate, dietary habits and activity levels all play a role. Comparing your week-eight progress with someone else's is rarely informative. For a fuller picture of the timeline specifically, our page on how long Wegovy takes to work covers the month-by-month picture in more detail. For those who want to understand how long semaglutide takes to work across its different forms, that page sets out what to expect at each stage of treatment. For those considering semaglutide in its injectable form more broadly, the semaglutide overview sets the wider context.

Side effects that affect the timeline, and when to act

The most common reason people question whether Wegovy is working is side effects, not lack of effect. Nausea, loose stools, constipation, burping and fatigue are well-documented during early treatment and after each dose increase, as the NHS medicines page for semaglutide outlines. These effects are typically mild to moderate and tend to resolve within one to two weeks of a new dose.

Managing them is part of the process. Smaller, lower-fat meals, staying hydrated and avoiding eating until uncomfortably full all reduce severity. Timing your meal well after the injection can help too. None of this changes the underlying timeline for weight loss, but poor tolerance early on can lead people to stop treatment before the dose reaches its therapeutic level, which cuts the process short.

There are symptoms that do need prompt attention. Severe stomach pain that extends to the back (with or without vomiting) should not be dismissed as ordinary nausea. The MHRA flagged acute pancreatitis as a rare but serious potential side effect in a Drug Safety Update published in January 2026. If you experience that kind of pain, stop the injection and seek urgent medical help. Suspected side effects can also be reported at the MHRA Yellow Card service. Gallbladder symptoms and signs of dehydration from prolonged vomiting or diarrhoea also warrant medical review rather than waiting it out.

Deciding whether Wegovy is the right fit for you

Wegovy suits people who are prepared for a gradual process measured in months, who can commit to the injection schedule, and whose clinical picture makes semaglutide the appropriate choice. It is not recommended during pregnancy, for those trying to conceive, during breastfeeding, or for anyone under 18. Certain medical histories, including pancreatitis, require careful prescriber assessment before treatment begins.

Cost is part of the decision too. Private treatment is not cheap, and the realistic timeframe for meaningful results means that commitment is financial as well as practical. Our Wegovy pricing page explains how private costs are structured, and what a single transparent price should include. For a comparison of how semaglutide's timeline compares with that of tirzepatide (Mounjaro), our weight-loss treatment overview covers both options side by side.

If you are already on treatment and wondering whether your experience is typical, the question of whether it is normal for Wegovy to take this long is one our clinical team fields regularly. The short answer is yes. Patience is part of the prescription. If you are ready to start that conversation properly, you can check your eligibility with our prescribers through a free consultation.